muricatocin A
isolated from leaves of the tropical tree Annona muricata; muricatocin A (C19/C20-threo, C10/C12-pseudo-erythro), B (C19/C20-erythro, C10/C12-pseudo-erythro), C (C19/C20-erythro, C10/C12-pseudo-threo); structure in first source
Also Known As:
muricatocin B; muricatocin C
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Cho, William C:
1 article
(01/2020)
|
| 2. | Egbuna, Chukwuebuka:
1 article
(01/2020)
|
| 3. | Flores-Holguín, Norma:
1 article
(01/2020)
|
| 4. | Frau, Juan:
1 article
(01/2020)
|
| 5. | Gaman, Mihnea-Alexandru:
1 article
(01/2020)
|
| 6. | Glossman-Mitnik, Daniel:
1 article
(01/2020)
|
| 7. | Kollur, Shiva Prasad:
1 article
(01/2020)
|
| 8. | Kosakowska, Olga:
1 article
(01/2020)
|
| 9. | Marraiki, Najat:
1 article
(01/2020)
|
| 10. | Ortega Castro, Joaquín:
1 article
(01/2020)
|
Related Diseases
| 1. | COVID-19
01/01/2020
- " In the current study, we have created a library of Acetogenins unique to the plant, comprising of Annomuricin A, Annomuricin B, Annomuricin C, Muricatocin C, Muricatacin, cis-Annonacin, Annonacin-10-one, cis-Goniothalamicin, Arianacin and Javoricin, for in silico and theoretical evaluations against the SARS-CoV-2 spike protein in an attempt toward promotion of plant based drug development for the current pandemic of coronavirus disease 2019 (COVID-19). "
|
|
Related Drugs and Biologics